We offer experienced staff:
Clinical Research Associate (CRA)
Senior Clinical Research Associate (S-CRA)
Regulatory Affair Manager
Freelance CRA
Our previous experience (indication & amount of sites):
Community-acquired Pneumonia
(phase III)
15 sites in Poland
(multinational trial with 130 sites)
Arterial Hypertension
(phase IV)
26 sites in Poland
(multinational trial with 60 sites)
Epilepsy
(phase II)
7 sites in Poland
(multinational trial with 20 sites)
Osteoarthritis
(phase lIa)
6 sites in Poland
(multinational trial with 18 sites)
Psoriasis
(phase lIa)
6 sites in Poland
(multinational trial with 20 sites)
(projected has been stopped)
Osteoarthritis
(phase III)
6 sites in Poland
(multinational trial with 12 sites)
Diabetic Retinopathy
(phase III)
6 sites in Poland
(multinational trial with 24 sites)
Epilepsy
(phase III)
8 sites in Poland
(multinational trial with 50 sites)
Hormone Replacement Therapy
(phase III)
4 sites in Poland
(multinational trial with 18 sites)
Osteoarthritis
(phase Ilb)
6 sites in Poland
(multinational trial with 42 sites)
Crohn's Disease
3 + 2 sites in Poland
(international study)
Bronchial Asthma
( phase III)
8 sites in Poland
(international study)
COPD
(phase III)
9 sites in Poland
(international study)
Gastric Ulcer
(phase III)
7 sites in Poland
(international study)
Duodenal Ulcer
(phase III)
6 sites in Poland,
(international study)
Reflux Disease
(phase III)
8 sites in Poland,
(international study)
Gastric Bleeding
(phase III)
2 sites in Poland,
(international study)
COPD
(phase II)
3 sites in Poland,
(international study)
Multiplex Sclerosis
(phase II)
8 sites in Poland
(international study)
VACCINATION STUDIES
Management, co-monitoring
